Traws Pharma (TRAW) Proxy Filing summary

Executive summary

• Annual meeting scheduled for November 21, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by November 20, 2025.

Voting matters and shareholder proposals

• Election of seven directors is on the agenda, with board recommendations provided.

• Amendment and restatement of the 2021 Incentive Compensation Plan up for approval.

• Advisory vote on executive compensation and on the frequency of future say-on-pay votes.

• Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2025.

• Proposal to allow adjournment of the meeting if more time is needed to solicit proxies.

Board of directors and corporate governance

• Seven nominees for director positions are listed for election at the annual meeting.